Federal Register of Legislation - Australian Government

Primary content

This instrument allows for Ministerial discretion to be exercised under subsection 99ACF(3AA) of the National Health Act 1953 for one brand of one pharmaceutical item with an approved ex-manufacturer price not reduced on 1 April 2022.
Administered by: Health and Aged Care
Registered 31 Mar 2022

Commonwealth Coat of Arms of Australia

 

 

I, Nikolai Tsyganov, Acting Assistant Secretary, Pricing and PBS Policy Branch, Technology Assessment and Access Division, Department of Health, delegate of the Minister for Health and Aged Care make this determination under subsection 99ACF(3AA) of the National Health Act 1953.

Dated 29 March 2022

 

 

 

 

 

 

 

 

 

NIKOLAI TSYGANOV

Acting Assistant Secretary

Pricing and PBS Policy Branch

Technology Assessment and Access Division

Department of Health

 

 

 

 

 

 

 

1              Name of Determination

                This instrument is the National Health (April 2022 First New Brand statutory price reduction) (Exercise of Ministerial discretion) Determination 2022.  

2              Commencement

                This instrument commences on 1 April 2022.

3              Definition

 

              Note: A number of expressions used in this instrument are defined in Part VII the Act,

 

In this instrument:

  

   Act means the National Health Act 1953.

4              Authority

 

This instrument is made under subsection 99ACF(3AA) of the Act.

5              Brand of pharmaceutical item with approved ex-manufacturer price not reduced

 

I determine under subsection 99ACF(3AA) of the Act that, for the purposes of subsection 99ACF(2AB), the approved ex-manufacturer price that comes into force on 1 April 2022 of the brand of pharmaceutical item specified in column 2 as an item in the table in Schedule 1 is to be worked out using a reduction of zero %.

 


Schedule 1 Brand of pharmaceutical item with approved ex-manufacturer price not reduced

 

Column 1

Column 2

Item

Brand of Pharmaceutical Item

 

Drug

Form

Manner of administration

Brand

1

Lacosamide

Oral solution 10 mg per mL, 200 mL

Oral

Vimpat